Infant Bacterial Therapeutics AB
IBT-B.ST
#9248
Rank
S$88.68 M
Marketcap
$6.58
Share price
-0.37%
Change (1 day)
-42.11%
Change (1 year)

Earnings for Infant Bacterial Therapeutics AB (IBT-B.ST)

Earnings in 2024 (TTM): -S$18.51 Million

According to Infant Bacterial Therapeutics AB's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$15.81 Million a decrease over its 2022 earnings that were of -S$8.74 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Infant Bacterial Therapeutics AB from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$18.51 Million17.06%
2023 -S$15.81 Million80.92%
2022 -S$8.74 Million25.19%
2021 -S$6.98 Million-36.99%
2020 -S$11.08 Million67.11%
2019 -S$6.63 Million6.6%
2018 -S$6.22 Million8.05%
2017 -S$5.76 Million